Literature DB >> 8329507

Brucellar sacroiliitis: findings in 63 episodes and current relevance.

J Ariza1, M Pujol, J Valverde, J M Nolla, G Rufí, P F Viladrich, J M Corredoira, F Gudiol.   

Abstract

Between 1974 and 1989 we prospectively observed 530 patients with brucellosis. The findings for 62 patients (42 males and 20 females; mean age, 34.7 years) with 63 episodes in which the sacroiliac joint was involved (the most frequent osteoarticular location [11.7%]) were analyzed. Ten of the older patients (mean age, 55.3 years) had concomitant spondylitis. Systemic symptoms were usually important, and characteristic pain and findings of sacroiliitis were observed in approximately 75% of cases. Blood cultures were positive for Brucella melitensis for 44 patients. The most frequent radiographic findings were blurring of articular margins (42 cases) and widening of the sacroiliac space (20 cases). No radiographic anomalies were detected in 13 cases. Results of 99mTc and gallium-67 bone scans were abnormal in approximately 90% of cases (abnormalities were often mild). Overall, clinical, radiographic, and isotopic bone scan findings were sensitive and useful, although they were occasionally minimal or difficult to evaluate, making diagnostic findings confusing or misleading. Brucellar sacroiliitis is a mild disease associated with a good outcome similar to that observed for patients with uncomplicated brucellosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8329507     DOI: 10.1093/clind/16.6.761

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  13 in total

1.  Brucellar prosthetic arthritis in a total knee replacement.

Authors:  A Ortí; P Roig; R Alcalá; V Navarro; M Salavert; C Martín; A Zorraquino; J Merino
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-11       Impact factor: 3.267

2.  Multiple abscesses in brucellosis with Wright's test negativity.

Authors:  Luca Dutto; Fulvio Pomero; Attilio Allione
Journal:  BMJ Case Rep       Date:  2009-02-27

3.  Clinical characteristics of human brucellosis in patients with various monoarticular involvements.

Authors:  Mile Bosilkovski; Marjan Zezoski; Dijana Siskova; Silvana Miskova; Vesna Kotevska; Nikola Labacevski
Journal:  Clin Rheumatol       Date:  2016-02-09       Impact factor: 2.980

4.  Rheumatologic manifestations of brucellosis.

Authors:  Behzad Heidari; Parham Heidari
Journal:  Rheumatol Int       Date:  2010-01-21       Impact factor: 2.631

5.  Could remembering the prozone phenomenon shorten our diagnostic journey in brucellosis? A case of Brucella spondylodiscitis.

Authors:  Gulay Sain Guven; Banu Cakir; Gul Oz; Mine Durusu Tanriover; Ercan Turkmen; Tumay Sozen
Journal:  Rheumatol Int       Date:  2006-02-17       Impact factor: 2.631

Review 6.  Brucella infection in total knee arthroplasty. Case report and revision of the literature.

Authors:  Enrico Tassinari; Daniele Di Motta; Federico Giardina; Francesco Traina; Marcello De Fine; Aldo Toni
Journal:  Chir Organi Mov       Date:  2008-03-27

Review 7.  Acute sacroiliitis.

Authors:  Gleb Slobodin; Doron Rimar; Nina Boulman; Lisa Kaly; Michael Rozenbaum; Itzhak Rosner; Majed Odeh
Journal:  Clin Rheumatol       Date:  2016-02-04       Impact factor: 2.980

8.  A 26-year-old man with sternoclavicular arthritis.

Authors:  Christian Gutierrez Ruiz; J Jaime Miranda; Georgios Pappas
Journal:  PLoS Med       Date:  2006-08       Impact factor: 11.069

9.  Osteoarticular tissue infection and development of skeletal pathology in murine brucellosis.

Authors:  Diogo M Magnani; Elizabeth T Lyons; Toni S Forde; Mohammed T Shekhani; Vyacheslav A Adarichev; Gary A Splitter
Journal:  Dis Model Mech       Date:  2013-03-08       Impact factor: 5.758

Review 10.  Brucellosis in patients infected with the human immunodeficiency virus.

Authors:  S Moreno; J Ariza; F J Espinosa; D Podzamczer; J M Miró; A Rivero; M Rodríguez-Zapata; J Arrizabalaga; R Mateos; F Herrero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.